Ghana Says NO to the US

Why Protecting National Health Data Is an Act of Sovereignty

When Accra walked away from a $109 million US health deal, it wasn’t just rejecting money. It was defending every Ghanaian’s most intimate secrets — and setting a precedent that the whole continent is watching.

Yesterday, Ghana quietly made one of the most consequential decisions of President John Mahama’s administration — and most people may not have noticed. Accra walked away from a proposed $109 million bilateral health agreement with the United States, after negotiations broke down over a single, non-negotiable American demand: access to Ghana’s sensitive national health data.

The deal was part of Washington’s “America First Global Health Strategy” — the Trump administration’s framework for restructuring foreign health aid after the dismantling of USAID. In exchange for five years of funding covering HIV/AIDS, malaria, tuberculosis, and polio programmes, the US wanted something that Ghana’s officials quietly determined was too valuable, too intimate, and too dangerous to hand over.

Ghana is not alone. It joins a quiet but growing coalition of nations — Zimbabwe, Kenya, Zambia — that have pushed back, walked out, or gone to court to protect the health data of their citizens from what critics are calling a new form of data extractivism dressed in humanitarian clothing.

What’s Actually Happening — And Why It Matters

To understand this story, you have to understand what “health data” really means. We are not talking about statistics in a spreadsheet. National health data is a living record of a country’s most vulnerable people — their HIV statuses, their tuberculosis diagnoses, their maternal health histories, their genetic profiles, their disease burdens broken down by region, age, and ethnicity. It is, in the most literal sense, a nation’s biological autobiography.

Under the proposed agreements, countries would be required to build “integrated health data systems” capable of sharing epidemiological trends and long-term surveillance information with the United States. The question that Ghana’s officials — and their counterparts in Harare and Nairobi — asked themselves was simple and devastating: what happens to that data once it crosses a border?

“Zimbabwe was being asked to share its biological resources and data over an extended period, with no corresponding guarantee of access to any medical innovations — such as vaccines, diagnostics, or treatments — that might result from that shared data.— Nick Mangwana, Zimbabwe Government Spokesperson, February 2026

Zimbabwe made the choice first, and most dramatically. On 25 February 2026, Harare formally rejected a $367 million health funding deal, after President Emmerson Mnangagwa — in a leaked internal memo — described the American offer as “lopsided” and instructed his ministers to discontinue negotiations. The US had reportedly demanded access to biological samples from Zimbabwean patients for research that could yield vaccines and treatments — with no mechanism to ensure Zimbabwe would share in any resulting benefits or intellectual property. It was, as Al Jazeera reported, aid structured as extraction.

Kenya signed an agreement in December 2025, then watched its own High Court suspend it — after a consumer rights group and a senator filed a legal challenge arguing that the deal violated Kenya’s Data Protection Act and bypassed parliamentary oversight. Kenya had already demonstrated its seriousness about data sovereignty when, in 2025, courts ordered the deletion of biometric data collected by Worldcoin from 300,000 Kenyan citizens. Zambia also raised alarms about the data-sharing clauses, with analysts noting that the country relies on PEPFAR for over 80% of its HIV funding — making any rejection a decision made at enormous personal cost to over 1.3 million people in treatment.

What Countries Cited as Response for Rejection

Data Protection Is Not Bureaucracy — It Is Human Rights

As a Data Protection Officer, I want to be precise about something that often gets lost in geopolitical framing: health data is the most sensitive category of personal data recognised under every serious data protection framework in the world — from the European Union’s General Data Protection Regulation (GDPR) to Ghana’s own Data Protection Act, 2012 (Act 843).

The reason is obvious when you think about it. Your health record tells a story that you may have told no one — your mental health history, your sexual health, your chronic conditions, your family’s genetic predispositions. In the wrong hands, this information can be used to discriminate in employment, deny insurance, stigmatise communities, or — in the case of conditions like HIV — expose individuals to violence and social exclusion. At national scale, it can be weaponised for profiling, exclusion, and geopolitical leverage.

When this data is held within a country’s own systems, governed by its own laws, and subject to its own courts, citizens have recourse. They can challenge misuse. They can demand accountability. But once that data leaves the country — to foreign servers, under foreign jurisdiction, governed by contracts they had no say in — that protection evaporates. The Africa CDC’s director captured it precisely: “We want to own our data in Africa. We want to own our future.”

The potential consequences of surrendering this data are not hypothetical. National health data from developing nations has historically been used to develop pharmaceutical products — vaccines, diagnostics, treatments — that are then sold back to those same nations at prices they cannot afford. It can be fed into artificial intelligence models that generate billions in commercial value for corporations based thousands of miles away, with zero benefit flowing back to the communities whose suffering informed the algorithm. It can be shared with insurance companies, foreign intelligence services, or private investors in ways that violate the fundamental dignity of every person whose record it contains.

“The central question for countries like Ghana is no longer just “how much money?” but “on what terms?”— Yoopya News Analysis, April 2026

The Cost of Saying Yes Would Have Been Incalculable

The $109 million sounds significant — and against the backdrop of Ghana’s real health financing gaps, it is. The US disbursed $96 million to Ghana’s health programmes in 2024 alone. Saying no to this deal is not cost-free. There will be funding gaps. There will be pressure on Ghana’s health budget. HIV programmes, malaria prevention, and tuberculosis treatment depend in part on this external support, and the people who will feel any reduction are the most vulnerable.

But consider the alternative with the eyes of a data protection officer. Once sensitive national health data is shared under a framework governed by US law, on US-controlled infrastructure, there is no practical mechanism to demand its return, restrict its secondary use, or prevent it from being commercialised. Ghana would have traded a permanent, irreversible, sovereign resource — the intimate health history of its citizens — for five years of conditional funding. That is not a partnership. That is a pawnshop transaction.

The Ghanaian experts and health tech leaders who warned at a 2025 digital-health dialogue that poor data governance could undermine AI’s promise in healthcare were not wrong. But the answer to weak domestic data systems is to strengthen them — not to embed them into long-term foreign agreements built on asymmetric terms.

A Word of Genuine Applause for Ghana’s Leadership

Commendation
President John Mahama and the Government of Ghana deserve our unreserved applause — and our gratitude. This was not an easy decision. Turning away over $100 million in health funding, in the face of real domestic health needs and sustained diplomatic pressure, required political courage of the highest order.What Ghana’s leadership did was demonstrate something that many governments, under similar pressure, have failed to do: they put the long-term interests and dignity of their citizens above short-term financial convenience. They understood — correctly — that national health data is a strategic national asset, not a bargaining chip. They read the fine print. They asked the hard questions. And when the answers were unacceptable, they walked away.In an era when data has become the most valuable resource in the world — more lucrative than oil, more strategically important than minerals — protecting the health data of 34 million Ghanaians is an act of leadership that will compound in value for generations. Ghana joins Zimbabwe and the Kenyan judiciary in affirming a truth that the whole continent must internalise: sovereignty in the 21st century is digital. And President Mahama’s government has shown Africa what a data-sovereign nation looks like.The rest of the continent is watching. They should follow this example.

What Must Come Next

Saying no is the beginning, not the end. Ghana’s Data Protection Commission must now use this moment to strengthen enforcement of Act 843, invest in domestic health data infrastructure, and build the regulatory capacity to engage future international health partnerships on genuinely equal terms. Ghanaian experts are already calling for a “sovereignty-first” model that keeps legal custody of health data with Ghanaian public institutions, demands explicit benefit-sharing clauses for any data used in AI or pharmaceutical research, and subjects any foreign-hosted systems to contracts aligned with Ghana’s own laws.

The World Health Organisation, which held a high-level health sovereignty summit in Accra in 2025, has urged African states to build digital health strategies that respect national laws and human rights while still engaging in global health surveillance networks. That balance is achievable — but only from a position of sovereign strength, not dependency.

Ghana has just claimed that position. Now the work begins to build upon it.